{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:32:35Z","timestamp":1791689555803,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jbspin.2004.09.005","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T17:23:58Z","timestamp":1100280238000},"page":"416-423","source":"Crossref","is-referenced-by-count":31,"title":["Effect of alendronate therapy in children with osteogenesis imperfecta"],"prefix":"10.1016","volume":"72","author":[{"given":"V\u00e1clav","family":"Vysko\u010dil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Pikner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160t\u011bp\u00e1n","family":"Kut\u00edlek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2004.09.005_bib1","series-title":"Pediatric bone. Biology and diseases","first-page":"443","article-title":"Osteogenesis imperfecta","author":"Plotkin","year":"2003"},{"key":"10.1016\/j.jbspin.2004.09.005_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.jbspin.2004.09.005_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00003086-198109000-00004","article-title":"Osteogenesis imperfecta: an expanding panorama of variants","volume":"159","author":"Sillence","year":"1981","journal-title":"Clin. Orthop."},{"key":"10.1016\/j.jbspin.2004.09.005_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.22203\/eCM.v005a04","article-title":"Osteogenesis imperfecta and molecular diversity","volume":"5","author":"Roughley","year":"2003","journal-title":"Europ Cells Mater"},{"key":"10.1016\/j.jbspin.2004.09.005_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2004.09.005_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1297-319X(01)00256-1","article-title":"Osteogenesis imperfecta: lifelong management is imperative and feasible","volume":"68","author":"Chevrel","year":"2001","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2004.09.005_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta","volume":"26","author":"Rauch","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.jbspin.2004.09.005_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00009957-200303000-00001","article-title":"Modern approach to children with osteogenesis imperfecta","volume":"12","author":"Zeitlin","year":"2003","journal-title":"J. Pediatr. Orthop. B"},{"key":"10.1016\/j.jbspin.2004.09.005_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2004.09.005_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0929-693X(00)00180-9","article-title":"Osteogenesis imperfecta: a new, early therapeutic approach with bisphosphonates. A case report","volume":"8","author":"Guillot","year":"2001","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jbspin.2004.09.005_bib11","first-page":"1491","article-title":"The use of bisphosphonates in children with osteogenesis imperfecta","volume":"14","author":"Glorieux","year":"2001","journal-title":"J Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2004.09.005_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1297-319X(01)00336-0","article-title":"Bisphosphonates in bone diseases other than osteoporosis","volume":"69","author":"Orcel","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2004.09.005_bib13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","article-title":"The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta","volume":"110","author":"Rauch","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbspin.2004.09.005_bib14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1172\/JCI0217051","article-title":"Modeling the benefits of pamidronate in children with osteogenesis imperfecta","volume":"110","author":"Lindsay","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jbspin.2004.09.005_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1359\/jbmr.2003.18.4.610","article-title":"Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy","volume":"18","author":"Rauch","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2004.09.005_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1542\/peds.111.5.1030","article-title":"Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV","volume":"111","author":"Zeitlin","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jbspin.2004.09.005_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1210\/jc.2002-021371","article-title":"Osteogenesis imperfecta types I, III and IV: effect of pamidronate on bone and mineral metabolism","volume":"88","author":"Rauch","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2004.09.005_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1542\/peds.111.5.e601","article-title":"Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta","volume":"111","author":"Montpetit","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jbspin.2004.09.005_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/JPEM.2002.15.2.163","article-title":"Pamidronate treatment of osteogenesis imperfecta -lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response","volume":"15","author":"Zacharin","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2004.09.005_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1297-319X(02)00434-7","article-title":"Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients","volume":"69","author":"Giraud","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2004.09.005_bib21","first-page":"562","article-title":"Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta","volume":"87","author":"Astrom","year":"2002","journal-title":"Arch. Dis. Child"},{"key":"10.1016\/j.jbspin.2004.09.005_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s004310100844","article-title":"Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta","volume":"160","author":"Lee","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jbspin.2004.09.005_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1542\/peds.111.3.573","article-title":"Intravenous bisphosphonate therapy in children with osteogenesis imperfecta","volume":"111","author":"Falk","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jbspin.2004.09.005_bib24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s004310050715","article-title":"Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate","volume":"156","author":"Landsmeer-Beker","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jbspin.2004.09.005_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/000992280204100512","article-title":"Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children","volume":"41","author":"Stuart","year":"2002","journal-title":"Clin. Pediatr."},{"key":"10.1016\/j.jbspin.2004.09.005_bib26","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(200009)43:9<1960::AID-ANR6>3.0.CO;2-J","article-title":"Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study","volume":"43","author":"Bianchi","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2004.09.005_bib27","first-page":"1786","article-title":"Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases","volume":"29","author":"Cimaz","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2004.09.005_bib28","first-page":"179","article-title":"Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year follow-up study","volume":"30","author":"Falcini","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2004.09.005_bib29","series-title":"Nation-wide anthropological survey of children and adolescents 1991 (Czech Republic)","author":"Lhotsk\u00e1","year":"1993"},{"key":"10.1016\/j.jbspin.2004.09.005_bib30","series-title":"Paediatric osteology: new developments in diagnostics and therapy","first-page":"103","article-title":"Measurement of bone mass and density in children","author":"Kroger","year":"1996"},{"key":"10.1016\/j.jbspin.2004.09.005_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00003086-198109000-00015","article-title":"Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management","volume":"159","author":"Bleck","year":"1981","journal-title":"Clin. Orthop."},{"key":"10.1016\/j.jbspin.2004.09.005_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2165\/00003495-199753030-00006","article-title":"Alendronate. A review of its pharmaceutical properties and therapeutic efficacy in postmenopausal osteoporosis","volume":"53","author":"Jeal","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.jbspin.2004.09.005_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/15246090050118125","article-title":"Alendronate in the treatment of osteoporosis: a review of the clinical trials","volume":"9","author":"Siris","year":"2000","journal-title":"J Woman Health Gender Based Med"},{"key":"10.1016\/j.jbspin.2004.09.005_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2004.09.005_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/JPEM.2000.13.2.217","article-title":"Effect of alendronate treatment on the clinical picture and bone turnover markers in chronic idiopathic hyperphosphatasia","volume":"13","author":"Demir","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2004.09.005_bib36","first-page":"894","article-title":"Oral bisphosphonates in polyostotic fibrous dysplasia","volume":"40","author":"Khadilkar","year":"2003","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.jbspin.2004.09.005_bib37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1542\/peds.111.4.899","article-title":"Oral bisphosphonate therapy for vitamin D intoxication of the infant","volume":"111","author":"Bereket","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jbspin.2004.09.005_bib38","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002230010045","article-title":"A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta","volume":"69","author":"Camacho","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jbspin.2004.09.005_bib39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1203\/00006450-200211000-00010","article-title":"Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model","volume":"52","author":"McCarthy","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jbspin.2004.09.005_bib40","first-page":"23","article-title":"Alendronate in treatment of osteoporosis in childhood (in Czech)","volume":"7","author":"Bayer","year":"2002","journal-title":"Osteol. Bull."},{"key":"10.1016\/j.jbspin.2004.09.005_bib41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1651-2227.2003.tb00577.x","article-title":"Treatment of children with osteogenesis imperfecta in Estonia","volume":"92","author":"Maasalu","year":"2003","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.jbspin.2004.09.005_bib42","series-title":"Pediatric bone. Biology and diseases","first-page":"303","article-title":"Noninvasive techniques for bone mass measurements","author":"Mora","year":"2003"},{"key":"10.1016\/j.jbspin.2004.09.005_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/JCD:7:1:17","article-title":"Diagnosis of osteoporosis in men, premenopausal women, and children","volume":"7","year":"2004","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.jbspin.2004.09.005_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","article-title":"New approaches for interpreting projected bone densitometry data","volume":"7","author":"Carter","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2004.09.005_bib45","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1359\/jbmr.2001.16.12.2298","article-title":"Total body bone mineral content and tibial cortical bone measures in school children","volume":"16","author":"Specker","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2004.09.005_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02526879","article-title":"Lumbar spine bone density in Argentine children","volume":"58","author":"Plotkin","year":"1996","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jbspin.2004.09.005_bib47","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1651-2227.1993.tb12554.x","article-title":"Serum concentrations of procollagen I C-terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with non-lethal osteogenesis imperfecta","volume":"82","author":"Brenner","year":"1993","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.jbspin.2004.09.005_bib48","series-title":"Paediatric osteology: new developments in diagnostics and therapy","first-page":"221","article-title":"Collagen and bone markers in patients with osteogenesis imperfecta","author":"Brenner","year":"1996"},{"key":"10.1016\/j.jbspin.2004.09.005_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/000992289903801201","article-title":"Bisphosphonates: from grandparents to grandchildren","volume":"38","author":"Srivastava","year":"1999","journal-title":"Clin. Pediatr."},{"key":"10.1016\/j.jbspin.2004.09.005_bib50","first-page":"921","article-title":"Use of bisphosphonates in children and adolescents","volume":"15","author":"Allgrove","year":"2002","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2004.09.005_bib51","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0929-693X(02)00006-4","article-title":"Bisphosphonates in children: present and future","volume":"9","author":"Konne\u00a0Paut","year":"2002","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.jbspin.2004.09.005_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1440-1754.2003.00083.x","article-title":"Use of bisphosphonate therapy for osteoporosis in childhood and adolescence","volume":"39","author":"Batch","year":"2003","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.jbspin.2004.09.005_bib53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00247-003-0865-1","article-title":"Radiographic features of bisphosphonate therapy in pediatric patients","volume":"33","author":"Grissom","year":"2003","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.jbspin.2004.09.005_bib54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJMoa023110","article-title":"Bisphosphonate-induced osteoporosis","volume":"349","author":"Whyte","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2004.09.005_bib55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMp038103","article-title":"Do Bisphosphonates make children\u2019s bones better or brittle?","volume":"349","author":"Marini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2004.09.005_bib56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005792-199707000-00005","article-title":"Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis","volume":"76","author":"Brumsen","year":"1997","journal-title":"Medicine"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X04001964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X04001964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T05:31:13Z","timestamp":1682832673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X04001964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1297319X04001964"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2004.09.005","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}